CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced that the Company will be presenting at the 2012 BD Biotech Conference on Tuesday, April 17 and Wednesday April 18, 2012, at the Mandarin Oriental in Boston, MA.
